These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31974736)

  • 1. Are dizziness-related symptoms signals for suboptimal treatment of hypothyroidism? New insights from the FDA adverse event reporting system (FAERS) database.
    Carnovale C; Battini V; Mazhar F; Mosini G; Gringeri M; Vicenzi A; Clementi E; Radice S
    Eur J Clin Pharmacol; 2020 May; 76(5):733-734. PubMed ID: 31974736
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases.
    Mukai R; Hasegawa S; Umetsu R; Nakao S; Shimada K; Uranishi H; Masuta M; Suzuki H; Nishibata Y; Nakamura M
    J Clin Pharm Ther; 2019 Apr; 44(2):285-291. PubMed ID: 30569470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between paracetamol and lamotrigine: new insights from the FDA Adverse Event Reporting System (FAERS) database.
    Carnovale C; Mosini G; Gringeri M; Battini V; Mazhar F; Pozzi M; Clementi E; Radice S
    Eur J Clin Pharmacol; 2019 Sep; 75(9):1323-1325. PubMed ID: 31201435
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.
    Nomura K; Takahashi K; Hinomura Y; Kawaguchi G; Matsushita Y; Marui H; Anzai T; Hashiguchi M; Mochizuki M
    Drug Des Devel Ther; 2015; 9():3031-41. PubMed ID: 26109846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
    Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
    Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a New Consumer Form on the Quantity and Quality of Adverse Event Reports Submitted to the United States Food and Drug Administration.
    Muñoz MA; Delcher C; Dal Pan GJ; Kortepeter CM; Wu E; Wei YJ; Xiao H; Winterstein AG
    Pharmacotherapy; 2019 Nov; 39(11):1042-1052. PubMed ID: 31479525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS).
    Zhang X; Hamadeh IS; Song S; Katz J; Moreb JS; Langaee TY; Lesko LJ; Gong Y
    J Bone Miner Res; 2016 Feb; 31(2):336-40. PubMed ID: 26288087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database.
    Shimada K; Hasegawa S; Nakao S; Mukai R; Sasaoka S; Ueda N; Kato Y; Abe J; Mori T; Yoshimura T; Kinosada Y; Nakamura M
    Int J Med Sci; 2019; 16(9):1295-1303. PubMed ID: 31588196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy in three different spontaneous adverse drug event databases.
    Mabuchi T; Hosomi K; Yokoyama S; Takada M
    Int J Clin Pharmacol Ther; 2020 Nov; 58(11):601-607. PubMed ID: 32729825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filing Sources after Oral P2Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS).
    Serebruany VL; Cherepanov V; Kim MH; Litvinov O; Cabrera-Fuentes HA; Marciniak TA
    Cardiology; 2017; 138(4):249-253. PubMed ID: 28898876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System.
    Zhang P; Li M; Chiang CW; Wang L; Xiang Y; Cheng L; Feng W; Schleyer TK; Quinney SK; Wu HY; Zeng D; Li L
    CPT Pharmacometrics Syst Pharmacol; 2018 Aug; 7(8):499-506. PubMed ID: 30091855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS).
    Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE
    Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS).
    Wittayanukorn S; Qian J; Johnson BS; Hansen RA
    J Oncol Pharm Pract; 2017 Mar; 23(2):93-102. PubMed ID: 26661047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS).
    Rahman MM; Alatawi Y; Cheng N; Qian J; Peissig PL; Berg RL; Page DC; Hansen RA
    Clin Drug Investig; 2017 Dec; 37(12):1143-1152. PubMed ID: 28933038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining big data search analytics and the FDA Adverse Event Reporting System database to detect a potential safety signal of mirtazapine abuse.
    Spachos D; Siafis S; Bamidis P; Kouvelas D; Papazisis G
    Health Informatics J; 2020 Sep; 26(3):2265-2279. PubMed ID: 32026758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
    Khadem TM; van Manen RP; Brown J
    Pharmacotherapy; 2014 Dec; 34(12):1324-9. PubMed ID: 25421400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database".
    Putzke J; Haughie S; Zou KH; Ranganna GM
    BioDrugs; 2021 May; 35(3):373-374. PubMed ID: 33860919
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERS.
    Ando G; Taguchi K; Enoki Y; Yokoyama Y; Kizu J; Matsumoto K
    Biol Pharm Bull; 2019; 42(11):1799-1804. PubMed ID: 31685764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.